Raymond V Fucini - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Biochemistry|March 17, 2009

Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tetheringWenjin Yang, Raymond V Fucini, Bruce T Fahr, et al.

Molecular Metabolism|November 30, 2025

Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesityManu V Chakravarthy, Ruben Rodriguez, Anne Hergarden, et al.

Cancer Chemotherapy and Pharmacology|August 4, 2009

SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivoJennifer P Arbitrario, Brian J Belmont, Marc J Evanchik, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Biochemistry|March 17, 2009

Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tetheringWenjin Yang, Raymond V Fucini, Bruce T Fahr, et al.

Molecular Metabolism|November 30, 2025

Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesityManu V Chakravarthy, Ruben Rodriguez, Anne Hergarden, et al.

Cancer Chemotherapy and Pharmacology|August 4, 2009

SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivoJennifer P Arbitrario, Brian J Belmont, Marc J Evanchik, et al.

Pageof 2